Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SonoSite aims for expansion with $200m note offer:

This article was originally published in Clinica

Executive Summary

Hand-carried ultrasound specialist SonoSite (Bothell, Washington) is set to offer $200m worth of convertible senior notes, with the aim of funding the possible acquisition of complementary businesses or product lines. The proceeds may also be used for debt repayment, capital expenditure, investment in subsidiaries, or as additional working capital. The notes will pay interest twice a year, at a rate of 3.75% each year, and, in certain circumstances, will be convertible based on an initial conversion price of around $38.2 per share. SonoSite has granted the underwriters a 30-day option to buy up to $25m aggregate principal amount of additional notes.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT049133

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel